Portfolio company
Morphotek
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops therapeutic monoclonal antibodies and protein products to treat cancer, inflammatory diseases, and infectious conditions for patients worldwide.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
FF Pharmaceuticals
This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.
Morphic Therapeutic
This biopharmaceutical company develops oral integrin therapies for patients with serious chronic diseases, including autoimmune conditions, fibrosis, and inflammatory bowel disease.
Arxx Therapeutics
This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.
Arsanis
This biotechnology company develops monoclonal antibodies to treat and prevent serious infectious diseases for patients with life-threatening bacterial and viral infections.
TORL BioTherapeutics
This biopharmaceutical company develops antibody-drug conjugates and monoclonal antibodies to treat various cancers for patients with unmet medical needs.
AgomAb Therapeutics
This biopharmaceutical company develops therapies to treat fibrotic and inflammatory diseases for patients with conditions such as Crohn's disease and pulmonary fibrosis.
Edesa Biotech
This biopharmaceutical company develops monoclonal antibody treatments for patients suffering from acute and chronic inflammatory and immune-related diseases.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
